Delivery Order SPE2DB20D1004-SPE2DB25FNEWW

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $4,836.13 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 15, 2024, with a completion date of February 16, 2024. The contract is not designated with a set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award is for the delivery of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,434.87 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 18, 2024, with a completion date of March 19, 2024. This appears to be a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $1,075.37 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 31, 2024 with a completion date of November 1, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a subsidiary of Cencora, Inc. The contract has a ceiling value of $12,050.28 and was awarded on November 8, 2021, with a completion date of November 9, 2021. The contract is a delivery order under a larger Indefinite...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,056.17 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2024, with a completion date of January 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,170.47 Firm Fixed Price Delivery Order covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through January 29, 2025. The contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 (60 count) pharmaceutical products to the Defense Logistics Agency (DLA). The $4,880.63 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM). The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S medication to the Defense Logistics Agency (DLA). The $14,256.62 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,281.73 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 6, 2024, with a completion date of May 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the...
This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The $4,717.20 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 17, 2024, with a completion date of December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEWW
    Delivery Order

This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $7,472.52 firm fixed price contract has a completion date of February 13, 2025 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/14/25, 10:14 AM